Evidence map›Paper›PMID 42268402›Full record

ArticleCancer immunology, immunotherapy : CII2026

Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients.

Lingling Wang, Yasi Xu, Yanyan Zhao, Bing Xia, Lucheng Zhu

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Lingling WangThe Fourth School of Clinical Medicine, Affiliated Zhejiang Chinese Medical University, Zhejiang, People's Republic of China.
Yasi XuThe Fourth School of Clinical Medicine, Affiliated Zhejiang Chinese Medical University, Zhejiang, People's Republic of China.
Yanyan ZhaoDepartment of Translational Medicine Research Center, School of Medicine, Affiliated Hangzhou First People's Hospital, Westlake University, Hangzhou, People's Republic of China.
Bing XiaDepartment of Thoracic Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang Chinese Medical University, No. 34, Yanguan Lane, Hangzhou, 310002, People's Republic of China.
Lucheng ZhuDepartment of Thoracic Oncology, Affiliated Hangzhou Cancer Hospital, Zhejiang Chinese Medical University, No. 34, Yanguan Lane, Hangzhou, 310002, People's Republic of China. zhulucheng1@zuaa.zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42268402
PMCPMC13253931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.